Volver a Agenda
Session Chair(s)
Nancy D. Smith, PHD
Adjunct Professor
Temple University, FDA Alumni, United States
Learning Objective : Summarize key issues discussed by CDER management; Identify regulatory hot topics in drug development and regulation.
Speaker(s)
Panelist
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Panelist
John Jenkins
JKJ Advisors, LLC, United States
Principal
Panelist
Justina Molzon, JD, MS
Consumer Services, United States
Consumer Services
Panelist
Christine Moore, PHD
Organon & Co., United States
Executive Director, Global External Advocacy and Standards
Panelist
Robert T. O'Neill, PHD
FDA, United States
Senior Statistical Advisor, Office of Translational Sciences, CDER
Panelist
Robert J. Temple, MD
FDA, United States
Senior Advisor for Clinical Science, OCD and Immediate Office, OND, CDER
¿Tiene una cuenta?